Attributes | Values |
---|
rdf:type
| |
Description
| - The treatment of multiple myeloma has undergone significant changes and has resulted in the achievement of molecular remissions, the prolongation of remission duration, and extended survival becoming realistic goals, with a cure being possible in a small but growing number of patients. In addition, nowadays it is possible to categorize patients more precisely into different risk groups, thus allowing the evaluation of therapies in different settings and enabling a better comparison of results across trials. Here, we review the evidence from clinical studies, which forms the basis for our recommendations for the management of patients with myeloma. Treatment approaches depend on %22fitness,%22 with chronological age still being an important discriminator for selecting therapy.
- The treatment of multiple myeloma has undergone significant changes and has resulted in the achievement of molecular remissions, the prolongation of remission duration, and extended survival becoming realistic goals, with a cure being possible in a small but growing number of patients. In addition, nowadays it is possible to categorize patients more precisely into different risk groups, thus allowing the evaluation of therapies in different settings and enabling a better comparison of results across trials. Here, we review the evidence from clinical studies, which forms the basis for our recommendations for the management of patients with myeloma. Treatment approaches depend on %22fitness,%22 with chronological age still being an important discriminator for selecting therapy. (en)
|
Title
| - European Perspective on Multiple Myeloma Treatment Strategies in 2014
- European Perspective on Multiple Myeloma Treatment Strategies in 2014 (en)
|
skos:prefLabel
| - European Perspective on Multiple Myeloma Treatment Strategies in 2014
- European Perspective on Multiple Myeloma Treatment Strategies in 2014 (en)
|
skos:notation
| - RIV/61988987:17110/14:A1501CFN!RIV15-MSM-17110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61988987:17110/14:A1501CFN
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Multiple myeloma; Risk stratification; Consolidation; Maintenance; Autologous stem cell transplantation; Nontransplant setting; Elderly patients (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Einsele, Hermann
- Hájek, Roman
- Sonneveld, Pieter
- Delforge, Michel
- Palumbo, Antonio
- Ludwig, Heinz
- Moreau, Philippe
- Dimopoulos, Meletios
- Facon, Thierry
- Goldschmidt, Hartmut
- Blade, Joan
- Boccadoro, Mario
- Cavo, Michele
- Morgan, Gareth
- Plesner, Torben
- Davies, Faith
- Nahi, Hareth
- San-Miguel, Jesus
- Sondergeld, Pia
- de la Rubia, Javier
|
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |